This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
AL Anderson , MS Reid , SH Li , T Holmes , . (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence 104, 133–139.
AK Banala , BA Levy , SS Khatri , CA Furman , . (2011). N-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl) piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity. Journal of Medicinal Chemistry 54, 581–594.
J Bergman , JB Kamien , RD Spealman (1990). Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behavioural Pharmacology 1, 355–363.
LH Brauer , H de Wit (1996). Subjective responses to d-amphetamine alone and after primozide pretreatment in normal, healthy volunteers. Biological Psychiatry 39, 26–32.
D Brody , LA Adler , T Kim , B Angrist , . (1990). Effects of buspirone in seven schizophrenic subjects. Journal of Clinical Psychopharmacology 10, 68–69.
F Bruno (1989). Buspirone in the treatment of alcoholic patients. Psychopathology 22 (Suppl. 1), 49–59.
PM Callahan , KA Cunningham (1997). Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists. Neuropharmacology 36, 373–381.
P Czobor , P Skolnick (2011). The secrets of a successful clinical trial: compliance, compliance, and compliance. Molecular Interventions 11, 107–110.
RC Dockens , DE Salazar , IE Fulmor , R Croop (2006). Pharmacokinetics of a newly identified metabolite of buspirone following administration of buspirone over its therapeutic dose range. Journal of Clinical Pharmacology 46, 1308–1312.
RC Dockens , AQ Tran , J Zeng , R Croop (2007). Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans. Biopharmaceutics and Drug Disposition 28, 393–402.
A Elkashef , PJ Fudala , L Gorgon , SH Li , . (2006). Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug and Alcohol Dependence 85, 191–197.
RE Gammans , RF Mayol , JA LaBudde (1986). Metabolism and disposition of buspirone. American Journal of Medicine 80 (Suppl. 3B), 41–51.
DC Goff , KK Midha , AW Brotman , S McCormick , . (1991). An open trial of buspirone added to neuroleptics in schizophrenic patients. Journal of Clinical Psychopharmacology 11, 193–197.
LH Gold , RL Balster (1992). Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys. Psychopharmacology 108, 289–294.
M Haney , AS Ward , RW Foltin , MW Fischman (2001). Effect of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration in humans. Psychopharmacology 155, 330–337.
MW Jann (1988). Buspirone: an update on a unique anxiolytic agent. Pharmacotherapy 8, 100–116.
R Kahn , K Biswas , AR Childress , S Shoptaw , . (2009). Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence 103, 59–64.
JB Kamien , WL Woolverton (1990). Buspirone blocks the discriminative stimulus effects of apomorphine in monkeys. Pharmacology Biochemistry and Behavior 35, 117–120.
M Kotler , H Cohen , R Segman , I Gritsenko , . (1997). Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Molecular Psychiatry 2, 251–254.
NS Kula , RJ Baldessarini , JW Kebabian , JL Neumeyer (1994). S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell and Molecular Neurobiology 14, 185–191.
M Laucht , K Becker , D Blomeyer , MH Schmidt (2007). Novelty seeking involved in mediating the association between the dopamine D4 receptor gene exon III polymorphism and heavy drinking in male adolescents: results from a high-risk community sample. Biological Psychiatry 61, 87–92.
B Le Foll , JC Schwartz , P Sokoloff (2000). Dopamine D3 receptor agents as potential new medications for drug addiction. European Psychiatry 15, 140–146.
B Le Foll , A Gallo , Y Le Strat , L Lu , . (2009). Genetics of dopamine receptors and drug addiction: a comprehensive review. Behavioural Pharmacology 20, 1–17.
JM Lusher , C Chandler , D Ball (2001). Dopamine D4 receptor gene (DRD4) is associated with novelty seeking (NS) and substance abuse: the saga continues. Molecular Psychiatry 6, 497–499.
TS Malec , EA Malec , M Dongier (1996). Efficacy of buspirone in alcohol dependence: a review. Alcoholism: Clinical and Experimental Research 20, 853–858.
FG Moeller , DM Dougherty , ES Barratt , JM Schmitz , . (2001). The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment 21, 193–198.
CP Müller , RJ Carey , JP Huston , MA De Souza Silva (2007). Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Progress in Neurobiology 81, 133–178.
MA Nader , WL Woolverton (1994). Blockade of the discriminative stimulus effects of d-amphetamine in rhesus monkeys with serotonin 5-HT(1A) agonists. Behavioural Pharmacology 5, 591–598.
Y Namkung , C Dipace , E Urizar , JA Javitch , . (2009). G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. Journal of Biological Chemistry 284, 34103–34115.
E Nann-Vernotica , EC Donny , GE Bigelow , SL Walsh (2001). Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155, 338–347.
SS Negus , NK Mello (2003). Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug and Alcohol Dependence 70, 39–52.
NG Schneider , RE Olmstead , C Steinberg , K Sloan , . (1996). Efficacy of buspirone in smoking cessation: a placebo-controlled trial. Clinical Pharmacology and Therapeutics 60, 568–575.
SK Shenoy , RJ Lefkowitz (2011). β-arrestin-mediated receptor trafficking and signal transduction. Trends in Pharmacological Sciences 32, 521–533.
MA Sherer , KM Kumor , JH Jaffe (1989). Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Research 27, 117–125.
P Sirota , B Epstein , R Benatov , M Sousnostzky , . (2001). An open study of buspirone augmentation of neuroleptics in patients with schizophrenia. Journal of Clinical Psychopharmacology 21, 454–455.
T Sumiyoshi , S Park , K Jayathilake , A Roy , . (2007). Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophrenia Research 95, 158–168.
SR Wachtel , A Ortengren , H de Wit (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug and Alcohol Dependence 68, 23–33.
H Wong , RC Dockens , L Pajor , S Yeola , . (2007). 6-hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats. Drug Metabolism and Disposition 35, 1387–1392.
ZX Xi , JG Gilbert , AC Pak , CR Ashby Jr., . (2005). Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. European Journal of Neuroscience 21, 3427–3438.
Y Yan , A Pushparaj , Y Le Strat , I Gamaleddin , . (2012). Blockade of dopamine D4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats. Neuropsychopharmacology 37, 685–696.
X Zhao , A Jones , KR Olsen , K Peng , . (2008). A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors. Journal of Biomolecular Screening 13, 737–747.